Vertex Pharmaceuticals (VRTX) Inventory Average (2011 - 2026)

Vertex Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 34.63% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 34.63% YoY), while the FY2025 annual figure was $1.4 billion, up 48.76% from the prior year.
• Inventory Average was $1.7 billion for Q1 2026 at Vertex Pharmaceuticals, up from $1.7 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.7 billion in Q1 2026 to a low of $346.0 million in Q1 2022.
• Historically, Inventory Average has averaged $903.9 million across 5 years, with a median of $775.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average grew 13.88% in 2022, then jumped 70.95% in 2023.
• A 5-year view of Inventory Average shows it stood at $424.4 million in 2022, then soared by 68.18% to $713.8 million in 2023, then soared by 60.08% to $1.1 billion in 2024, then surged by 45.0% to $1.7 billion in 2025, then gained by 4.22% to $1.7 billion in 2026.
• The last three Inventory Average figures came in at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.